Books > Medicine > Nursing & ancillary services > Biomedical engineering
|
Buy Now
3D Printing of Pharmaceuticals (Hardcover, 1st ed. 2018)
Loot Price: R4,486
Discovery Miles 44 860
|
|
3D Printing of Pharmaceuticals (Hardcover, 1st ed. 2018)
Series: AAPS Advances in the Pharmaceutical Sciences Series, 31
Expected to ship within 10 - 15 working days
|
3D printing is forecast to revolutionise the pharmaceutical sector,
changing the face of medicine development, manufacture and use.
Potential applications range from pre-clinical drug development and
dosage form design through to the fabrication of functionalised
implants and regenerative medicine. Within clinical pharmacy
practice, printing technologies may finally lead to the concept of
personalised medicines becoming a reality. This volume aims to be
the definitive resource for anyone thinking of developing or using
3D printing technologies in the pharmaceutical sector, with a
strong focus on the translation of printing technologies to a
clinical setting. This text brings together leading experts to
provide extensive information on an array of 3D printing
techniques, reviewing the current printing technologies in the
pharmaceutical manufacturing supply chain, in particular,
highlighting the state-of-the-art applications in medicine and
discussing modern drug product manufacture from a regulatory
perspective. This book is a highly valuable resource for a range of
demographics, including academic researchers and the pharmaceutical
industry, providing a comprehensive inventory detailing the current
and future applications of 3D printing in pharmaceuticals. Abdul W.
Basit is Professor of Pharmaceutics at the UCL School of Pharmacy,
University College London. Abdul's research sits at the interface
between pharmaceutical science and gastroenterology, forging links
between basic science and clinical outcomes. He leads a large and
multidisciplinary research group, and the goal of his work is to
further the understanding of gastrointestinal physiology by
fundamental research. So far, this knowledge has been translated
into the design of new technologies and improved disease
treatments, many of which are currently in late-stage clinical
trials. He has published over 350 papers, book chapters and
abstracts and delivered more than 250 invited research
presentations. Abdul is also a serial entrepreneur and has filed 25
patents and founded 3 pharmaceutical companies (Kuecept, Intract
Pharma, FabRx). Abdul is a frequent speaker at international
conferences, serves as a consultant to many pharmaceutical
companies and is on the advisory boards of scientific journals,
healthcare organisations and charitable bodies. He is the European
Editor of the International Journal of Pharmaceutics. Abdul was the
recipient of the Young Investigator Award in Pharmaceutics and
Pharmaceutical Technology from the American Association of
Pharmaceutical Scientists (AAPS) and is the only non-North American
scientist to receive this award. He was also the recipient of the
Academy of Pharmaceutical Sciences (APS) award. Simon Gaisford
holds a Chair in Pharmaceutics and is Head of the Department of
Pharmaceutics at the UCL School of Pharmacy, University College
London. He has published 110 papers, 8 book chapters and 4 authored
books. His research is focused on novel technologies for
manufacturing medicines, particularly using ink-jet printing and 3D
printing, and he is an expert in the physico-chemical
characterisation of compounds and formulations with thermal methods
and calorimetry.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
You might also like..
|